PT3106459T - Derivado da indolona substituído com pirrole, seu método de preparação, composição que compreende o mesmo e sua utilização - Google Patents

Derivado da indolona substituído com pirrole, seu método de preparação, composição que compreende o mesmo e sua utilização

Info

Publication number
PT3106459T
PT3106459T PT15746066T PT15746066T PT3106459T PT 3106459 T PT3106459 T PT 3106459T PT 15746066 T PT15746066 T PT 15746066T PT 15746066 T PT15746066 T PT 15746066T PT 3106459 T PT3106459 T PT 3106459T
Authority
PT
Portugal
Prior art keywords
pyrrole
preparation
composition
same
method therefor
Prior art date
Application number
PT15746066T
Other languages
English (en)
Inventor
Hu Lihong
Zhao Shaohua
Liu Peng
Li Xiangjun
An Junyong
Zhou Mengxia
Zhang Lili
Yao Zijian
Original Assignee
Shijiazhuang Yiling Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shijiazhuang Yiling Pharmaceutical Co Ltd filed Critical Shijiazhuang Yiling Pharmaceutical Co Ltd
Publication of PT3106459T publication Critical patent/PT3106459T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
PT15746066T 2014-02-10 2015-02-04 Derivado da indolona substituído com pirrole, seu método de preparação, composição que compreende o mesmo e sua utilização PT3106459T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410046278.2A CN104829596B (zh) 2014-02-10 2014-02-10 吡咯取代吲哚酮类衍生物、其制备方法、包含该衍生物的组合物、及其用途

Publications (1)

Publication Number Publication Date
PT3106459T true PT3106459T (pt) 2018-10-18

Family

ID=53777341

Family Applications (1)

Application Number Title Priority Date Filing Date
PT15746066T PT3106459T (pt) 2014-02-10 2015-02-04 Derivado da indolona substituído com pirrole, seu método de preparação, composição que compreende o mesmo e sua utilização

Country Status (17)

Country Link
US (1) US9556154B2 (pt)
EP (1) EP3106459B1 (pt)
JP (1) JP6211205B2 (pt)
KR (1) KR101805693B1 (pt)
CN (1) CN104829596B (pt)
AU (1) AU2015215335B2 (pt)
BR (1) BR112016018371B1 (pt)
CA (1) CA2939012C (pt)
ES (1) ES2687418T3 (pt)
MX (1) MX369473B (pt)
MY (1) MY176521A (pt)
PL (1) PL3106459T3 (pt)
PT (1) PT3106459T (pt)
RU (1) RU2650682C2 (pt)
SA (1) SA516371644B1 (pt)
SG (1) SG11201606545SA (pt)
WO (1) WO2015117551A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017079132A1 (en) 2015-11-02 2017-05-11 Dolby Laboratories Licensing Corporation Layered representation containing crc codes and delivery of high dynamic range video
CN108727341B (zh) * 2017-04-13 2021-02-19 勤浩医药(苏州)有限公司 一种吡咯取代吲哚酮类衍生物或其药学上可接受的盐、及它们的制备方法和用途
CN108191835A (zh) * 2018-01-09 2018-06-22 中国药科大学 一类新型的含吡咯环和吲哚啉结构rip1激酶抑制剂及其用途
RS65150B1 (sr) * 2018-09-19 2024-02-29 Suzhou Genhouse Pharmaceutical Co Ltd Pirol-supstituisan derivat indolona ili njegova farmaceutski prihvatljiva so i postupak njihove pripreme i njihova primena
CN109232580A (zh) * 2018-11-14 2019-01-18 南阳师范学院 一种1H-吡咯并[1,2-a]吲哚-2(3-H)-酮的合成方法
CN112321568B (zh) * 2020-09-22 2023-02-17 南京中医药大学 4-甲基吡咯取代的吲哚酮衍生物、其制备方法及其医药用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060814A2 (en) 2000-02-15 2001-08-23 Sugen, Inc. Pyrrole substituted 2-indolinone protein kinase inhibitors
AR035721A1 (es) * 2000-12-20 2004-07-07 Sugen Inc Indolinonas 4-aril sustituidas; sus composiciones farmaceuticas y metodo para modular la actividad catalitica de una proteina quinasa
WO2002081466A1 (en) * 2001-04-09 2002-10-17 Sugen, Inc. Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
EP1434774A1 (en) * 2001-10-10 2004-07-07 Sugen, Inc. 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
US7109185B2 (en) * 2001-11-21 2006-09-19 Sugen, Inc. Pharmaceutical formulations comprising indolinone derivatives
TW200418836A (en) * 2002-09-10 2004-10-01 Pharmacia Italia Spa Formulations comprising an indolinone compound
CN101007801A (zh) * 2006-01-27 2007-08-01 上海恒瑞医药有限公司 吡咯取代的2-二氢吲哚酮衍生物、其制法与医药上的用途
CN101553482B (zh) * 2006-09-15 2013-11-20 艾科睿制药公司 激酶抑制剂化合物
RU2525114C2 (ru) * 2007-12-03 2014-08-10 Бёрингер Ингельхайм Интернациональ Гмбх Способ получения производного индолинона
CN102066362B (zh) * 2008-05-23 2014-07-30 上海医药工业研究院 二氢吲哚酮衍生物
CN102276584A (zh) * 2010-06-08 2011-12-14 齐鲁制药有限公司 吡咯取代的2-二氢吲哚酮衍生物、其制备方法及用途
CN103130744B (zh) 2012-08-28 2014-10-15 沈阳药科大学 一种硒唑甲酸类化合物及其制备方法和用途

Also Published As

Publication number Publication date
SG11201606545SA (en) 2016-09-29
CN104829596B (zh) 2017-02-01
RU2650682C2 (ru) 2018-04-17
EP3106459A1 (en) 2016-12-21
US20160347740A1 (en) 2016-12-01
KR101805693B1 (ko) 2017-12-06
MY176521A (en) 2020-08-13
MX369473B (es) 2019-11-08
ES2687418T3 (es) 2018-10-25
CA2939012A1 (en) 2015-08-13
RU2016136351A3 (pt) 2018-03-15
WO2015117551A1 (zh) 2015-08-13
AU2015215335B2 (en) 2017-07-27
US9556154B2 (en) 2017-01-31
BR112016018371A2 (pt) 2017-10-17
AU2015215335A1 (en) 2016-09-01
KR20160117605A (ko) 2016-10-10
PL3106459T3 (pl) 2018-11-30
CN104829596A (zh) 2015-08-12
MX2016010272A (es) 2017-02-06
SA516371644B1 (ar) 2019-08-29
EP3106459A4 (en) 2017-07-12
RU2016136351A (ru) 2018-03-15
JP6211205B2 (ja) 2017-10-11
EP3106459B1 (en) 2018-07-04
CA2939012C (en) 2018-11-06
JP2017505803A (ja) 2017-02-23
BR112016018371B1 (pt) 2022-06-14

Similar Documents

Publication Publication Date Title
HK1251551A1 (zh) 氮雜環丁烷衍生物、其製備方法及用途
PL3214081T3 (pl) Pochodna izoindoliny, półprodukt, sposób wytwarzania, kompozycja farmaceutyczna i ich zastosowanie
HRP20181105T1 (hr) Novi pripravci, upotreba i postupci za njihovo dobivanje
EP3183349A4 (en) Methods for preparing rebaudioside i and uses
PT3215147T (pt) Compostos de norcetamina neuroatenuante e métodos
PL3104718T3 (pl) Kompozycja żelowa zawierająca tytoń
EP3153561A4 (en) Composition for heat cycle system and heat cycle system
EP3109302A4 (en) Composition for heat cycle system, and heat cycle system
EP3109301A4 (en) Composition for heat cycle system, and heat cycle system
EP3153567A4 (en) Composition for heat cycle system and heat cycle system
EP3109304A4 (en) Composition for heat cycle system, and heat cycle system
EP3109291A4 (en) Composition for heat cycle system, and heat cycle system
EP3109303A4 (en) Composition for heat cycle system, and heat cycle system
EP3112437A4 (en) Composition for heat cycle system, and heat cycle system
SG11201608711RA (en) Material itq-55, method for preparation and use
EP3109298A4 (en) Composition for heat cycle system, and heat cycle system
EP3115361A4 (en) Heterocyclic compounds, and preparation method and use thereof
IL246879B (en) Preparations of Epilimod and methods of using them
PT3106459T (pt) Derivado da indolona substituído com pirrole, seu método de preparação, composição que compreende o mesmo e sua utilização
EP3199541A4 (en) Cyclic peptide derivative, method for preparing same and composition thereof
PT3157912T (pt) Composições parasiticidas compreendendo derivados de indole, seus métodos e suas utilizações
HK1243995A1 (zh) α-細辛醇酯及其製備方法與應用
EP3130340A4 (en) Isoacteoside derivative and preparation method and use thereof
IL247220A0 (en) Amino pyrazoline derivatives, preparations containing them and their uses
EP3237399A4 (en) Compounds, compositions and methods